Lamellar Biomedical, of Bellshill, Scotland, raised £5.75 million (US$7.4 million) in a series C equity funding round. The financing was led by Invesco Asset Management Ltd. acting as agent for its clients and supported by the Scottish Investment Bank, the investment arm of Scottish Enterprise, both current investors in Lamellar.